Chemours Company (The) (CC): Price and Financial Metrics
Chemours Company (The) (CC)
Today's Latest Price: $15.26 USD
Updated Jul 9 6:40pm
Add CC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CC Stock Summary
- Chemours Co's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 95.62% of US listed stocks.
- CC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 92.12% of US stocks.
- As for revenue growth, note that CC's revenue has grown -13.18% over the past 12 months; that beats the revenue growth of merely 14.93% of US companies in our set.
- Stocks that are quantitatively similar to CC, based on their financial statements, market capitalization, and price volatility, are ENR, ADNT, DK, IGT, and TWI.
- CC's SEC filings can be seen here. And to visit Chemours Co's official web site, go to www.chemours.com.
CC Stock Price Chart Technical Analysis Charts
CC Price/Volume Stats
| Current price | $15.26 | 52-week high | $20.73 |
| Prev. close | $15.64 | 52-week low | $7.02 |
| Day low | $14.94 | Volume | 1,448,200 |
| Day high | $15.66 | Avg. volume | 2,990,666 |
| 50-day MA | $14.09 | Dividend yield | 6.55% |
| 200-day MA | $14.60 | Market Cap | 2.51B |
Chemours Company (The) (CC) Company Bio
The Chemours Company is a global leader in titanium technologies, fluoroproducts and chemical solutions. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. The company was founded in 2015 and is based in Wilmington, Delaware.
CC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $15.26 | $14.75 | -7% |
We started the process of determining a valid price forecast for Chemours Co with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Chemours Co ranked in the 46th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 6.5%. As for the metrics that stood out in our discounted cash flow analysis of Chemours Co, consider:
- The company's debt burden, as measured by earnings divided by interest payments, is 0.27 -- which is good for besting merely 22.57% of its peer stocks (US stocks in the Basic Materials sector with positive cash flow).
- 38% of the company's capital comes from equity, which is greater than merely 20.74% of stocks in our cash flow based forecasting set.
- Chemours Co's effective tax rate, as measured by taxes paid relative to net income, is at 216 -- greater than 98.6% of US stocks with positive free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -9% |
| 1% | -8% |
| 2% | -7% |
| 3% | -6% |
| 4% | -5% |
| 5% | -4% |
SXC, FF, PPG, ARLP, and IOSP can be thought of as valuation peers to CC, in the sense that they are in the Basic Materials sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...